Efficacy study of intensive cis‐platin therapy in advanced non‐small cell bronchogenic carcinoma

Steven E. Vogl, Marc Berenzweig, Fernando Camacho, Edward Greenwald, Barry H. Kaplan

Research output: Contribution to journalArticle

42 Scopus citations

Abstract

Thirty patients with advanced non‐small cell bronchogenic carcinoma were treated with cis‐platin, 75 mg/M2 weekly for three weeks, then every three weeks. Eighteen were ambulatory, 22 had distant metastases, 14 had prior irradiation, and none had prior chemotherapy. Ten patients (33%) had objective remissions lasting a median of three months. Responders lived a median of five months, compared to three months for nonresponders. Transient mild azotemia was noted in twelve patients. Cis‐platin has definite but modest activity in non‐small cell bronchogenic carcinoma.

Original languageEnglish (US)
Pages (from-to)24-26
Number of pages3
JournalCancer
Volume50
Issue number1
DOIs
StatePublished - Jul 1 1982

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Efficacy study of intensive cis‐platin therapy in advanced non‐small cell bronchogenic carcinoma'. Together they form a unique fingerprint.

  • Cite this